Chronic Myeloproliferative Disorders Unknown Status Phase 1 Trials for Amifostine (DB01143)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Unknown Status1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004036Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced CancerSupportive Care